Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio

About this episode

Jodie Morrison discusses her career in biotech leadership and the importance of mission-driven teams and community support.

In this episode of the Nucleate podcast, Jodie Morrison, CEO of Q32 Bio, discusses her extensive career path from clinical research to executive leadership. She explains her strategic approach to leading companies, particularly in challenging "fixer-upper" scenarios where she prioritizes finding assets with "good bones" and building high-performing, mission-driven teams. She also details Q32 Bio's current focus on autoimmune disorders like alopecia areata, emphasizing the pursuit of safer biologic treatments for patients who currently face significant unmet needs. Beyond her corporate role, Morrison highlights her efforts to foster community among biotech leaders through the founding of the CEO Forum during the COVID-19 pandemic. She advocates for transparency and mentorship, particularly for women in the industry, encouraging them to "lift while they climb". Looking ahead, she expresses cautious optimism for the biotech sector, noting that while capital markets and public sentiment present hurdles, the persistent reality of human disease ensures a continuous need for scientific advancement and new therapies.

People in this episode

Guest: Jodie Morrison

Topics covered

• biotechnology
• leadership
• autoimmune disorders
• mentorship
• community building

Keywords

• biotech
• leadership
• autoimmune disorders
• mentorship
• Q32 Bio
• CEO Forum
• transparency

Mentioned in this episode

Organizations: Q32 Bio, CEO Forum

Places: COVID-19

More episodes of Nucleate Podcast

• From Genomics to Deal-Making: How Science Becomes a Company | Laurence Reid, Biotech Entrepreneur · March 24, 2026 · 1h 36m
• Negotiating Intellectual Property, Staying Focused, and Making the Most of Mentors with Michal Preminger, Board Member at MassBio · March 10, 2026 · 1h 8m
• How Turbine Accelerates Drug Discovery with AI Simulation | Szabi Nagy, CEO and Co-Founder of Turbine · February 24, 2026 · 57 min
• The Science of Stem Cells and Social Impact: Inside Ovelle with Merrick Smela and Travis Potter · February 10, 2026 · 50 min
• Inside TechBio Investing | Claire Smith, Partner at Springtide VC · January 27, 2026 · 1h 3m
• Functional Precision Oncology, a new compass for cancer care | Apricot Bio · December 20, 2025 · 1h 23m